2.890EUR-0.34%Mkt Cap: 11.35M EURP/E: —Last update: 2026-05-14
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a n…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B-0.72
P/S15.59
EV/EBITDA-4.44
EV/Revenue20.96
EPS (TTM)-1.06
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-11.17%
FCF Margin-174.09%
Operating CF-3.72M EUR
CapEx (TTM)5.39K EUR
Net Debt/EBITDA-1.30
Net Debt4.46M EUR
Technical
SMA 503.080 (-6.2%)
SMA 2003.184 (-9.2%)
Beta0.26
S&P 52W Chg24.23%
Avg Vol (30d)652
Avg Vol (10d)546
Technical Indicators
RSI (14)42.1
MACD-0.0723
MACD Signal-0.0570
MACD Hist.-0.0154
BB Upper3.233 EUR
BB Middle2.991 EUR
BB Lower2.750 EUR
BB Width16.12%
ATR (14)0.1055 EUR
Vol Ratio (20d)1.05x
52W Range
2.70013% of range4.190
52W High4.190 EUR
52W Low2.700 EUR
Profitability
Gross Margin97.76%
EBITDA Margin0.00%
Profit Margin32137.35%
Oper. Margin-402.94%
ROE-4653.75%
ROA8128.24%
Revenue Growth148.70%
Earnings Growth—
Balance Sheet
Debt/Equity-1.16
Current Ratio0.45
Quick Ratio0.43
Book Value/Sh-4.0020 EUR
Cash/Share0.1180 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.3.94M
Float—
Insiders69.05%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap11.35M EUR
Enterprise Value15.26M EUR
Revenue (TTM)728.08K EUR
Gross Profit604.24K EUR
Net Income (TTM)198.63M EUR
Revenue/Share0.1930 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees27
Last Price2.890 EUR
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISIN—